Posted by Michael Wonder on 10 Jun 2025
DoH publishes revised agenda for July 2025 PBAC meeting (version 4)
10 June 2025 - The DoH has published a revised agenda for next month's PBAC meeting.
There are a few major changes:
- Influenza vaccine (trivalent) - new indication
- Influenza vaccine (trivalent, adjuvanted) - new indication
- Pembrolizumab (Keytruda) - proposal for an expanded listing to facilitate broad access for patients with unresectable advanced and metastatic cancer
- Nivolumab (Opdivo) - proposal for an expanded listing to facilitate broad access for patients with unresectable advanced and metastatic cancer
